MC

502.4

+2.91%↑

SANES

7.344

-2.51%↓

ALV

348.1

-2.03%↓

BNP

77.88

-0.88%↓

BBVA

13.375

-1.73%↓

MC

502.4

+2.91%↑

SANES

7.344

-2.51%↓

ALV

348.1

-2.03%↓

BNP

77.88

-0.88%↓

BBVA

13.375

-1.73%↓

MC

502.4

+2.91%↑

SANES

7.344

-2.51%↓

ALV

348.1

-2.03%↓

BNP

77.88

-0.88%↓

BBVA

13.375

-1.73%↓

MC

502.4

+2.91%↑

SANES

7.344

-2.51%↓

ALV

348.1

-2.03%↓

BNP

77.88

-0.88%↓

BBVA

13.375

-1.73%↓

MC

502.4

+2.91%↑

SANES

7.344

-2.51%↓

ALV

348.1

-2.03%↓

BNP

77.88

-0.88%↓

BBVA

13.375

-1.73%↓

Search

AB Science SA

Geschlossen

1.392 2.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

1.304

Max

1.398

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.4M

Verkäufe

512K

Gewinnspanne

-656.641

Angestellte

28

EBITDA

-1.9M

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Sept. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

92M

Vorheriger Eröffnungskurs

-1.42

Vorheriger Schlusskurs

1.392

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

AB Science SA Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

10. Juli 2025, 21:42 UTC

Akquisitionen, Fusionen, Übernahmen

Justice Department Won't Seek Injunction for T-Mobile Acquisition of U.S. Cellular

10. Juli 2025, 17:06 UTC

Akquisitionen, Fusionen, Übernahmen

Portugal Begins Process to Sell Stake in National Carrier -- Update

10. Juli 2025, 17:00 UTC

Wichtige Markttreiber

K Wave Media Shares Drop After Convertible Note Agreement With Anson Funds

10. Juli 2025, 16:31 UTC

Akquisitionen, Fusionen, Übernahmen

Blackstone Makes $664 Million Counteroffer for Warehouse REIT Amid Bidding War -- 2nd Update

10. Juli 2025, 23:47 UTC

Market Talk

Gold Edges Higher Amid Lingering Global Trade Tensions -- Market Talk

10. Juli 2025, 23:40 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

10. Juli 2025, 22:36 UTC

Market Talk

Tourism Holdings' Profit Warning Less Concerning Than Others -- Market Talk

10. Juli 2025, 22:23 UTC

Market Talk

New Law Creates Winners and Losers Among Renewable-Energy Projects -- Market Talk

10. Juli 2025, 20:50 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

10. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juli 2025, 20:00 UTC

Akquisitionen, Fusionen, Übernahmen

Toyota Tsusho America Completes Acquisition of Radius Recycling

10. Juli 2025, 19:56 UTC

Market Talk

Gold Rises on Inflation Concerns -- Market Talk

10. Juli 2025, 19:33 UTC

Market Talk

Oil Snaps Winning Streak As Oversupply Concerns Return -- Market Talk

10. Juli 2025, 19:21 UTC

Market Talk

U.S. Natural Gas Rebound on Benign Storage Build -- Market Talk

10. Juli 2025, 18:46 UTC

Market Talk

Mexican Industrial Production Seen as Mixed in May -- Market Talk

10. Juli 2025, 18:15 UTC

Market Talk

Brazil's Bullish Outlook Expected to Survive Trump Tariffs -- Market Talk

10. Juli 2025, 18:03 UTC

Market Talk
Ergebnisse

Travel Agency Investors Cautiously Optimistic After Delta Report -- Market Talk

10. Juli 2025, 17:57 UTC

Market Talk

US Labor Shortage Could Weigh on Business, Economic Growth -- Market Talk

10. Juli 2025, 17:34 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Conagra Falls While Simply Good Foods Adapts. What's Eating Food Companies. -- Barrons.com

10. Juli 2025, 17:34 UTC

Market Talk

Canada Vows Fight Over Trump's Copper Tariffs -- Market Talk

10. Juli 2025, 17:20 UTC

Market Talk

Copper Climbs as Futures Wrangle With Trump Tariff -- Market Talk

10. Juli 2025, 17:20 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

10. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. Juli 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10. Juli 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. Juli 2025, 16:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Juli 2025, 16:02 UTC

Market Talk

Global Equities Roundup: Market Talk

10. Juli 2025, 16:02 UTC

Market Talk

Embraer Expected to Bear Brunt of U.S. Tariffs on Brazil -- Market Talk

10. Juli 2025, 16:01 UTC

Akquisitionen, Fusionen, Übernahmen

Investor AB: Advanced Instruments' Acquisition of Nova Biomedical Completed

10. Juli 2025, 15:41 UTC

Market Talk

U.S. Natural Gas Storage Surplus Holds Steady -- Market Talk

Peer-Vergleich

Kursveränderung

AB Science SA Prognose

Technischer Score

By Trading Central

1.426 / 1.448Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bullish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.